Arthur DeCillis

2016

In 2016, Arthur DeCillis earned a total compensation of $332.7K as Chief Medical Officer at Eleven Biotherapeutics.

Compensation breakdown

Option Awards$215,860
Salary$116,855
Total$332,715

DeCillis received $215.9K in option awards, accounting for 65% of the total pay in 2016.

DeCillis also received $116.9K in salary.

Rankings

In 2016, Arthur DeCillis' compensation ranked 12,423rd out of 14,075 executives tracked by ExecPay. In other words, DeCillis earned more than 11.7% of executives.

ClassificationRankingPercentile
All
12,423
out of 14,075
12th
Division
Manufacturing
4,867
out of 5,489
11th
Major group
Chemicals And Allied Products
1,730
out of 1,895
9th
Industry group
Drugs
1,408
out of 1,538
9th
Industry
Pharmaceutical Preparations
1,086
out of 1,176
8th
Source: SEC filing on April 7, 2017.

DeCillis' colleagues

We found four more compensation records of executives who worked with Arthur DeCillis at Eleven Biotherapeutics in 2016.

2016

Abbie Celniker

Eleven Biotherapeutics

Chief Executive Officer

2016

Stephen Hurly

Eleven Biotherapeutics

Chief Executive Officer

2016

John McCabe

Eleven Biotherapeutics

Chief Financial Officer

2016

Karen Tubridy

Eleven Biotherapeutics

Former Chief Development Office

In-depth

You may also like